Differences in disease prevalence as a source of the U.S.-European health care spending gap.
The United States spends more on health care than any European country. Previous studies have sought to explain these differences in terms of system capacity, access to technologies, gross domestic product, and prices. We examine differences in disease prevalence and treatment rates for ten of the most costly conditions between the United States and ten European countries using surveys of the noninstitutionalized population age fifty and older. Disease prevalence and rates of medication treatment are much higher in the United States than in these European countries. Efforts to reduce the U.S. prevalence of chronic illness should remain a key policy goal.
Thorpe
Kenneth E
KE
Department of Health Policy and Management, Rollins School of Public Health, at Emory University, in Atlanta, Georgia, USA. kthorpe@sph.emory.edu
Howard
David H
DH
Galactionova
Katya
K
D000368:Aged; D002908:Chronic Disease / Q000191:economics / Q000453:epidemiology*; D005102:Health Expenditures / Q000706:statistics & numerical data*; D054625:Healthcare Disparities; D006801:Humans; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D012959:Socioeconomic Factors; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology